Melanoma follow up: time to generate the evidence

References

[1]  Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia: an overview. Canberra: AIHW; 2010.

[2]  Australian Cancer Network Melanoma Guidelines Revision Working Party. Clinical practice guidelines for the management of melanoma in Australia and New Zealand, Cancer Council Australia and Australian Cancer Network. Wellington: Sydney and New Zealand Guidelines Group; 2008.

[3]  Gamble RG, Jensen D, Suarez AL, Hanson AH, McLaughlin L, Duke J, et al Outpatient follow-up and secondary prevention for melanoma patients. Cancers 2010; 2 1178–97.
| Outpatient follow-up and secondary prevention for melanoma patients.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DC%2BC3cXnslGitbo%3D&md5=4c6318bb81bc45c1f7ba96ec54ecb396CAS |

[4]  Australian Institute of Health and Welfare, Cancer Australia, Australasian Association of Cancer Registries. Cancer survival and prevalence in Australia: cancers diagnosed from 1982 to 2004. Canberra: AIHW; 2008.

[5]  Australian Institute of Health and Welfare (AIHW). Cancer in adolescents and young adults in Australia. Canberra: AIHW; 2011.

[6]  Titus-Ernstoff L, Perry AE, Spencer SK, Gibson J, Ding J, Cole B, et al Multiple primary melanoma: two-year results from a population-based study. Arch Dermatol 2006; 142 433–8.
| Multiple primary melanoma: two-year results from a population-based study.Crossref | GoogleScholarGoogle Scholar | 16618861PubMed |

[7]  Bradford PT, Freedman DM, Goldstein AM, Tucker MA. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 2010; 146 265–72.
| Increased risk of second primary cancers after a diagnosis of melanoma.Crossref | GoogleScholarGoogle Scholar | 20231496PubMed |

[8]  Yang GB, Barnholtz-Sloan JS, Chen Y, Bordeaux JS. Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer. Arch Dermatol 2011; 147 1395–402.
| Risk and survival of cutaneous melanoma diagnosed subsequent to a previous cancer.Crossref | GoogleScholarGoogle Scholar | 22184761PubMed |

[9]  Turner RM, Bell KJ, Morton RL, Hayen A, Francken AB, Howard K, et al Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma. J Clin Oncol 2011; 29 4641–6.
| Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma.Crossref | GoogleScholarGoogle Scholar | 22067399PubMed |

[10]  Otsu U, Fukui N, Iki M, Moriwaki S, Kiyokane K. Case of cutaneous malignant melanoma surviving 16 years with late recurrence. J Dermatol 2009; 36 598–603.
| Case of cutaneous malignant melanoma surviving 16 years with late recurrence.Crossref | GoogleScholarGoogle Scholar | 19878393PubMed |

[11]  Tomas S. Recurring melanoma – a case study. Aust Fam Physician 2007; 36 1015–6, 1024.
| 18075626PubMed |

[12]  Bichakjian CK, Halpern AC, Johnson TM, Foote Hood A, Grichnik JM, Swetter SM, et al Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol 2011; 65 1032–47.
| Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology.Crossref | GoogleScholarGoogle Scholar | 21868127PubMed |

[13]  Marsden JR, Newton-Bishop JA, Burrows L, Cook M, Corrie PG, Cox NH, et al Revised UK guidelines for the management of cutaneous melanoma 2010. J Plast Reconstr Aesthet Surg 2010; 63 1401–19.
| Revised UK guidelines for the management of cutaneous melanoma 2010.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3cjpvFSlsw%3D%3D&md5=035cfff83b4e464c5b85b48e1549fc06CAS | 20728418PubMed |

[14]  Virgo KS, Chan D, Handler BS, Johnson DY, Goshima K, Johnson FE. Current practice of patient follow-up after potentially curative resection of cutaneous melanoma. Plast Reconstr Surg 2000; 106 590–7.
| 1:STN:280:DC%2BD3cvnsVGjsQ%3D%3D&md5=fc2131f20e398d018ebef725a63a9a43CAS | 10987465PubMed |

[15]  Cromwell KD, Ross MI, Xing Y, Gershenwald JE, Royal RE, Lucci A, et al Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review. Melanoma Res 2012; 22 376–85.
| Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.Crossref | GoogleScholarGoogle Scholar | 22914178PubMed |

[16]  Mitchell J, Street J, Bessen T, Neuhaus S. The patient experience of melanoma follow-up: an on-line survey. In Flinders Centre for Innovation in Cancer (FCIC) Survivorship Conference; 1–3 February 2013. Adelaide. Available at http://fcic-2013.p.asnevents.com.au/event/abstract/4370 [Verified 16 August 2013]

[17]  Rychetnik L, McCaffery K, Morton R, Irwig L. Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: a systematic review of the literature. Psychooncology 2013; 22 721–36.
| 22431448PubMed |

[18]  Kasparian NA, McLoone JK, Butow PN. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 2009; 145 1415–27.
| Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature.Crossref | GoogleScholarGoogle Scholar | 20026852PubMed |

[19]  Garbe C, Paul A, Kohler-Spa H, Ellwanger U, Stroebel W, Schwarz M, et al Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy. J Clin Oncol 2003; 21 520–9.
| Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy.Crossref | GoogleScholarGoogle Scholar | 12560444PubMed |

[20]  Garbe C. A rational approach to the follow-up of melanoma patients. Recent Results Cancer Res 2002; 160 205–15.
| A rational approach to the follow-up of melanoma patients.Crossref | GoogleScholarGoogle Scholar | 12079215PubMed |

[21]  Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27 6199–206.
| Final version of 2009 AJCC melanoma staging and classification.Crossref | GoogleScholarGoogle Scholar | 19917835PubMed |

[22]  Brazier A, Cooke K, Moravan V. Using mixed methods for evaluating an integrative approach to cancer care: a case study. Integr Cancer Ther 2008; 7 5–17.
| Using mixed methods for evaluating an integrative approach to cancer care: a case study.Crossref | GoogleScholarGoogle Scholar | 18292590PubMed |

[23]  Haji Ali Afzali H, Gray J, Beilby J, Holton C, Banham D, Karnon J. A risk-adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetes. Diabet Med 2013; 30 855–63.
| A risk-adjusted economic evaluation of alternative models of involvement of practice nurses in management of type 2 diabetes.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3srms1WjsA%3D%3D&md5=a1959bf57614ae030ddc5f9e457a7069CAS | 23600375PubMed |

[24]  Wolin KY, Colditz GA. Design and conduct of intervention-based research among cancer survivors. Cancer Epidemiol Biomarkers Prev 2011; 20 2078–84.
| Design and conduct of intervention-based research among cancer survivors.Crossref | GoogleScholarGoogle Scholar | 21980015PubMed |

[25]  Smith G, Wales C. Citizen juries and deliberative democracy. Polit Stud 2000; 48 51–65.
| Citizen juries and deliberative democracy.Crossref | GoogleScholarGoogle Scholar |

[26]  Morton RL, Rychetnik L, McCaffery K, Thompson JF, Irwig L. Patients’ perspectives of long-term follow-up for localised cutaneous melanoma. Eur J Surg Oncol 2013; 39 297–303.
| Patients’ perspectives of long-term follow-up for localised cutaneous melanoma.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BC3s3ms1WqsQ%3D%3D&md5=0b7161588ddcfe6af60cd6335d7bd5e7CAS | 23287820PubMed |

[27]  Rychetnik L, Morton RL, McCaffery K, Thompson JF, Menzies SW, Irwig L. Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians’ perspectives and models of care. BMC Health Serv Res 2012; 12 468
| Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians’ perspectives and models of care.Crossref | GoogleScholarGoogle Scholar | 23253951PubMed |